- Home
- CLDX vs BELFB Comparison
CLDX vs BELFB Comparison
Compare CLDX & BELFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- BELFB
- Stock Information
- Founded
- CLDX N/A
- BELFB 1949
- Country
- CLDX United States
- BELFB United States
- Employees
- CLDX N/A
- BELFB N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BELFB
- Sector
- CLDX Health Care
- BELFB
- Exchange
- CLDX Nasdaq
- BELFB Nasdaq
- Market Cap
- CLDX 1.6B
- BELFB 1.8B
- IPO Year
- CLDX 2008
- BELFB N/A
- Fundamental
- Price
- CLDX $24.50
- BELFB $145.86
- Analyst Decision
- CLDX Strong Buy
- BELFB Strong Buy
- Analyst Count
- CLDX 9
- BELFB 4
- Target Price
- CLDX $46.13
- BELFB $129.75
- AVG Volume (30 Days)
- CLDX 1.6M
- BELFB 115.3K
- Earning Date
- CLDX 11-05-2025
- BELFB 10-22-2025
- Dividend Yield
- CLDX N/A
- BELFB 0.19%
- EPS Growth
- CLDX N/A
- BELFB N/A
- EPS
- CLDX N/A
- BELFB 4.05
- Revenue
- CLDX $5,790,000.00
- BELFB $594,034,000.00
- Revenue This Year
- CLDX N/A
- BELFB $25.48
- Revenue Next Year
- CLDX N/A
- BELFB $5.57
- P/E Ratio
- CLDX N/A
- BELFB $35.90
- Revenue Growth
- CLDX N/A
- BELFB 6.08
- 52 Week Low
- CLDX $14.40
- BELFB $58.00
- 52 Week High
- CLDX $47.00
- BELFB $150.67
- Technical
- Relative Strength Index (RSI)
- CLDX 57.57
- BELFB 63.65
- Support Level
- CLDX $22.44
- BELFB $141.20
- Resistance Level
- CLDX $25.51
- BELFB $150.67
- Average True Range (ATR)
- CLDX 1.22
- BELFB 4.59
- MACD
- CLDX 0.20
- BELFB -0.19
- Stochastic Oscillator
- CLDX 75.78
- BELFB 76.58
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About BELFB Bel Fuse Inc. Class B
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.